Screener
MBX Biosciences, Inc. MBX Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by MBX Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The source filing: MBX Biosciences, Inc.’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 9:03 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-210593
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Cash and cash equivalents | $45,214 | $75,289 |
| Marketable securities | 394,763 | 298,416 |
| Prepaid expenses and other current assets | 8,559 | 7,834 |
| Total current assets | 448,536 | 381,539 |
| Property and equipment, net | 3,133 | 2,735 |
| Right-of-use assets | 453 | 487 |
| Other assets | 579 | 383 |
| Total assets | $452,701 | $385,144 |
Item 1. Financial Statements.
FAQ
- What is MBX Biosciences, Inc.'s total current assets?
- MBX Biosciences, Inc. (MBX) reported total current assets of $448.54M in Q1 2026.
- How has MBX Biosciences, Inc.'s total current assets changed year-over-year?
- MBX Biosciences, Inc.'s total current assets increased by 83.6% year-over-year, from $244.28M to $448.54M.
- What is the long-term trend for MBX Biosciences, Inc.'s total current assets?
- Over 2 years (2023 to 2025), MBX Biosciences, Inc.'s total current assets has grown at a 113.8% compound annual growth rate (CAGR), from $83.47M to $381.54M.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.
Ask your AI about MBX Biosciences, Inc.'s total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude